• HOME
  • ABOUT US
    • ABOUT THE COMPANY
    • THE TEAM
    • CHIEF EXECUTIVE OFFICER
    • CHIEF PHYSICIAN ADVISOR
    • CLINICAL NEUROSCIENCE
    • BIOTECHNOLOGY ADVISOR
    • COMPANY PRESIDENT
    • CHIEF FINANCIAL OFFICER
  • FORZA™
    • ABOUT FORZA™
    • THE STORY
    • THE SOURCE
    • THE PLAN
    • CALORIE RESTRICTION
    • VIRTUAL LIBRARY
  • REVIEWS
    • THE REVIEWS
    • IN LONG COVID
    • IN ALZHEIMER'S DISEASE
    • IN PARKINSON'S DISEASE
    • IN LEWY BODY DEMENTIA
    • IN MULTIPLE SCLEROSIS
    • IN DIABETES
    • IN LUPUS ERYTHEMATOSUS
    • IN SPINAL CORD INJURY
    • IN ARTHRITIS & PAIN
    • IN MIGRAINE & DEPRESSION
    • INFLAMMATION & INSOMNIA
  • WEBINARS
    • WEBINAR GALLERY
    • THE BIOLOGY OF AGING
    • ALZHEIMER'S DISEASE
    • PARKINSON'S DISEASE
    • DEPRESSION
    • FRONTOTEMPORAL DEMENTIAS
    • MULTIPLE SYSTEM ATROPHY
  • CONTACT US
  • Altro
    • HOME
    • ABOUT US
      • ABOUT THE COMPANY
      • THE TEAM
      • CHIEF EXECUTIVE OFFICER
      • CHIEF PHYSICIAN ADVISOR
      • CLINICAL NEUROSCIENCE
      • BIOTECHNOLOGY ADVISOR
      • COMPANY PRESIDENT
      • CHIEF FINANCIAL OFFICER
    • FORZA™
      • ABOUT FORZA™
      • THE STORY
      • THE SOURCE
      • THE PLAN
      • CALORIE RESTRICTION
      • VIRTUAL LIBRARY
    • REVIEWS
      • THE REVIEWS
      • IN LONG COVID
      • IN ALZHEIMER'S DISEASE
      • IN PARKINSON'S DISEASE
      • IN LEWY BODY DEMENTIA
      • IN MULTIPLE SCLEROSIS
      • IN DIABETES
      • IN LUPUS ERYTHEMATOSUS
      • IN SPINAL CORD INJURY
      • IN ARTHRITIS & PAIN
      • IN MIGRAINE & DEPRESSION
      • INFLAMMATION & INSOMNIA
    • WEBINARS
      • WEBINAR GALLERY
      • THE BIOLOGY OF AGING
      • ALZHEIMER'S DISEASE
      • PARKINSON'S DISEASE
      • DEPRESSION
      • FRONTOTEMPORAL DEMENTIAS
      • MULTIPLE SYSTEM ATROPHY
    • CONTACT US
  • HOME
  • ABOUT US
    • ABOUT THE COMPANY
    • THE TEAM
    • CHIEF EXECUTIVE OFFICER
    • CHIEF PHYSICIAN ADVISOR
    • CLINICAL NEUROSCIENCE
    • BIOTECHNOLOGY ADVISOR
    • COMPANY PRESIDENT
    • CHIEF FINANCIAL OFFICER
  • FORZA™
    • ABOUT FORZA™
    • THE STORY
    • THE SOURCE
    • THE PLAN
    • CALORIE RESTRICTION
    • VIRTUAL LIBRARY
  • REVIEWS
    • THE REVIEWS
    • IN LONG COVID
    • IN ALZHEIMER'S DISEASE
    • IN PARKINSON'S DISEASE
    • IN LEWY BODY DEMENTIA
    • IN MULTIPLE SCLEROSIS
    • IN DIABETES
    • IN LUPUS ERYTHEMATOSUS
    • IN SPINAL CORD INJURY
    • IN ARTHRITIS & PAIN
    • IN MIGRAINE & DEPRESSION
    • INFLAMMATION & INSOMNIA
  • WEBINARS
    • WEBINAR GALLERY
    • THE BIOLOGY OF AGING
    • ALZHEIMER'S DISEASE
    • PARKINSON'S DISEASE
    • DEPRESSION
    • FRONTOTEMPORAL DEMENTIAS
    • MULTIPLE SYSTEM ATROPHY
  • CONTACT US

9D Biotech News & Events

2020

DR. WILLIAM BITHONEY, MD FAAP JOINS 9D BIOTECH

We are proud and honoured to announce that Dr. William Bithoney, MD FAAP has joined the 9D Biotech team as Chief Physician Advisor and Chief Science Officer. 


Dr. Bithoney brings his invaluable expertise as a leading physician and highly experienced healthcare professional with more than 35 years of experience in the healthcare sector, having served as a physician executive in diverse academic and hospital systems. He is skilled in developing managed care strategies, academic strategies, a self-sustaining cycle of continuous performance and quality improvement, utilization review, utilization management, and research directions.
Dr. Bithoney's participation in 9D Biotech signals a new and important stage of the company's growth and confirms Forza's great potential to improve human health-span, life-span, and well being. 

2019

RADIO ITALIA INTERVIEW

MARCH 30TH, 2019 

Dr. Bruno Ruggiero, Ph.D., Einstein Visa recipient, biotech pioneer and CEO of 9th Dimension Biotech, Inc. presents Osmotin vs. Aging   

9DBIOTECH CEO & PATIENTS AT ITALY'S PRIME MINISTER'S OFFICE

9D Biotech presents FORZA at the Italian 2019 World Rare Disease Day Convention

February 28th, 2019

9D Biotech presented FORZA - our first Osmotin-rich product - at the Rare Diseases Event of the Office of the Prime Minister of Italy.

"I wish to express my sincere gratitude for your participation at the convention I organized in occasion of the 12th annual world rare disease day."
dr.ssa Antonella Picariello

coll. sen. Marco Croatti 

Our CEO, Dr. Bruno Ruggiero, was honored to be invited and to participate at the multilateral convention aimed at shining a light on rare pathologies, providing additional support to research and better assistance to patients by offering a platform for doctors, patients, non-profit organisations, researchers, and political representatives to exchange ideas and discuss innovative approaches together at the highest institutional levels in Italy. 


A special invitation was also extended by the organizers to a diabetes-associated peripheral neuropathy patient from Monte Carlo (see picture above), who had had a fantastic experience with our Forza product and wished to testify about such experience before the Ministry, as part of Dr. Ruggiero's presentation of the results of his latest scientific work. 

Learn More

Click on the link below to visit the Italian Ministry of Health's website and learn more about Italy's New National Plan for Rare Disease.

#RareDiseaseDay, verso il nuovo Piano nazionale malattie rare

SALUTE.GOV.IT

XII GIORNATA MONDIALE MALATTIE RARE, "LE MALATTIE RARE E LA DISABILITÀ" PROGRAMME AND ATTENDEES

NON-PROFIT ORGANISATIONS, PATIENTS, AND LEADING MEDICAL INSTITUTIONS JOINING FORCES FOR REAL CHANGE.

NON-PROFIT ORGANISATIONS, PATIENTS, AND LEADING MEDICAL INSTITUTIONS JOINING FORCES FOR REAL CHANGE.

Click below to view the official document issued by the Office of the Prime Minister announcing the Programme and Attendees of the Convention. 

ANNOUNCEMENT

NON-PROFIT ORGANISATIONS, PATIENTS, AND LEADING MEDICAL INSTITUTIONS JOINING FORCES FOR REAL CHANGE.

NON-PROFIT ORGANISATIONS, PATIENTS, AND LEADING MEDICAL INSTITUTIONS JOINING FORCES FOR REAL CHANGE.

NON-PROFIT ORGANISATIONS, PATIENTS, AND LEADING MEDICAL INSTITUTIONS JOINING FORCES FOR REAL CHANGE.

Learn more about the event from Mitocon - Italy's main Mitochondrial Diseases association. 

MITOCON.IT

2018

9D BIOTECH SUPER PLANTS SELECTED AS BEST BIOTECHNOLOGY PRODUCT AT ICBE 2018

9D BIOTECH SUPER PLANTS SELECTED AS BEST BIOTECHNOLOGY PRODUCT AT ICBE 2018

9D BIOTECH SUPER PLANTS SELECTED AS BEST BIOTECHNOLOGY PRODUCT AT ICBE 2018

9D Biotech is proud to announce that our Osmotin over-expressing Olive Trees and Osmotin over expressing Kiwi Vines were selected as the best biotechnology product for the environment and agriculture by the Independent Scientific panel of The 2nd International Conference of Biotechnology and Environment (ICBE 2018) held on the 28-30 March, 2018 in Alexandria, Egypt. Our partner team of Tuscia University, Italy, lead by Professor Eddo Rugini, were invited to presented the work as opening speakers of the conference. 

SEEDS AND CHIPS GLOBAL FOOD INNOVATION SUMMIT, MILAN, ITALY

9D BIOTECH SUPER PLANTS SELECTED AS BEST BIOTECHNOLOGY PRODUCT AT ICBE 2018

9D BIOTECH SUPER PLANTS SELECTED AS BEST BIOTECHNOLOGY PRODUCT AT ICBE 2018

9D Biotech had the pleasure to present our Osmotin age-reversing product line at the 2017 Seeds and Chips Global Food Innovation Summit held this May 8th-11th in Milan, Italy, with the 44th President of the United States of America Barack H. Obama being the guest of honor and keynote speaker at the Symposium. 

VISIT SEEDSANDCHIPS.COM NOW

THE FORZA™ CLINICAL TRIAL

PARTNERING FOR PATIENTS

9D BIOTECH's revolutionary anti-aging supplement FORZA™ is now in a phase 2 clinical trial in Progressive Multiple Sclerosis in partnership with the Italian National Multiple Sclerosis Association and Foundation, the General Hospital of San Martino, in Genoa, Italy, and the Sant'Andrea Medical and Psychology Hospital at La Sapienza University in Rome, Italy.

  • HOME
  • CALORIE RESTRICTION
  • VIRTUAL LIBRARY

Copyright © 2024

9th Dimension Biotech, Inc.

All Rights Reserved.

Gestito da

This site uses cookies to offer you a better browsing experience

We use cookies to analyze website traffic and optimize user experience.
By accepting, you agree that your data will be aggregated with the data of all other users.

Accept